AcelRx Pharmaceuticals' Series C Round

AcelRx Pharmaceuticals raised a round of funding on November 20, 2009.

AcelRx Pharmaceuticals is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of acute and breakthrough pain. AcelRx's lead product candi…

Articles about AcelRx Pharmaceuticals' Series C Round: